Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Masato Odawara, Munehide Matsuhisa, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka & Yasuo Terauchi. (2020) Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study). Expert Opinion on Pharmacotherapy 21:14, pages 1771-1780.
Read now
Read now
Shin-ichi Harashima, Akiko Nishimura & Nobuya Inagaki. (2017) Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study. Expert Opinion on Pharmacotherapy 18:1, pages 5-11.
Read now
Read now
Masato Odawara, Hitoshi Ishii, Naoko Tajima & Yasuhiko Iwamoto. (2016) Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study. Current Medical Research and Opinion 32:4, pages 681-686.
Read now
Read now
Takeo Suzuki, Ryoko Takei, Toyoshi Inoguchi, Noriyuki Sonoda, Shuji Sasaki, Toshihiko Kaise & Ryoichi Takayanagi. (2015) Clinical significance of barriers to blood glucose control in type 2 diabetes patients with insufficient glycemic control. Patient Preference and Adherence 9, pages 837-845.
Read now
Read now
Articles from other publishers (17)
Kentaro Okazaki, Noriyuki Takahashi, Tomotaka Shingaki, Magaly Perez-Nieves & Heather Stuckey. (2022) Key factors for overcoming psychological insulin resistance: A qualitative study in Japanese people with type 2 diabetes. Primary Care Diabetes 16:3, pages 411-416.
Crossref
Crossref
Ricardo Nicolás Alonso, Aníbal Chertcoff, María Bárbara Eizaguirre, Johana Bauer, Felisa Leguizamón, María Celeste Curbello, Fátima Pagani Cassará, Orlando Garcea, Adriana Carrá, Alejandra Palma & Berenice Anabel Silva. (2022) Decision making process in multiple sclerosis: An Argentine pilot study. Multiple Sclerosis and Related Disorders 61, pages 103751.
Crossref
Crossref
Takuyuki Katabami, Kirsten T. Eriksen, Yuiko Yamamoto & Yasushi Ishigaki. (2021) Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study. Advances in Therapy 39:1, pages 544-561.
Crossref
Crossref
Narihito Yoshioka. (2020) Current Status and Issues of Diabetes Treatment—How to Deal with Elderly Patients with Type 2 Diabetes—日本総合健診医学会 第48回大会・教育講演2 糖尿病診療の現状と課題─高齢2型糖尿病患者への対応─. Health Evaluation and Promotion 47:5, pages 553-558.
Crossref
Crossref
Celia Oreja-Guevara, Stanca Potra, Birgit Bauer, Diego Centonze, Maria-Paz Giambastiani, Gavin Giovannoni, Jürg Kesselring, Dawn Langdon, Sarah A. Morrow, Jocelyne Nouvet-Gire, Maija Pontaga, Peter Rieckmann, Sven Schippling, Nektaria Alexandri, Jane Shanahan, Heidi Thompson, Pieter Van Galen, Patrick Vermersch & David Yeandle. (2019) Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care. Advances in Therapy 36:11, pages 3238-3252.
Crossref
Crossref
Kentaro Okazaki, Tomotaka Shingaki, Zhihong Cai, Magaly Perez-Nieves & Lawrence Fisher. (2019) Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes. Diabetes Therapy 10:5, pages 1823-1834.
Crossref
Crossref
Kathy Ellis, Henrietta Mulnier & Angus Forbes. (2018) Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Family Practice 19:1.
Crossref
Crossref
Jennifer Okemah, John Peng & Manuel Quiñones. (2018) Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review. Advances in Therapy 35:11, pages 1735-1745.
Crossref
Crossref
Jo Satoh, Marc Andersen, Brian Bekker Hansen, Brian Larsen Thorsted, Deniz Tutkunkardas, Mette Zacho & Hiroshi Maegawa. (2018) Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43). PLOS ONE 13:9, pages e0198160.
Crossref
Crossref
Narihito Yoshioka. (2018) Psychological reluctance to insulin therapy: as an illness side of diabetes mellitus. Diabetology International 9:2, pages 82-83.
Crossref
Crossref
Naomi Iihara, Eri Ohara, Takayuki Nishio, Hiroshi Muguruma, Eitoku Matsuoka, Hitoshi Houchi & Yutaka Kirino. (2017) Patient Preference for Aggressive Medication Therapies with Potentially Stronger Adverse Drug Reactions Revealed Using a Scenario-based Survey. YAKUGAKU ZASSHI 137:9, pages 1161-1167.
Crossref
Crossref
Abdulaziz Bin rsheed & Ian Chenoweth. (2017) Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World Journal of Diabetes 8:1, pages 28.
Crossref
Crossref
Uwe Klaus Zettl, Ulrike Bauer-Steinhusen, Thomas Glaser, Klaus Hechenbichler & Michael Hecker. (2016) Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy. BMC Neurology 16:1.
Crossref
Crossref
Takashi Kadowaki, Hideaki Jinnouchi, Kohei Kaku, Malene L Hersløv, Jacob Hyllested‐Winge & Shuji Nakamura. (2016) Efficacy and safety of once‐daily insulin degludec dosed flexibly at convenient times vs fixed dosing at the same time each day in a Japanese cohort with type 2 diabetes: A randomized, 26‐week, treat‐to‐target trial. Journal of Diabetes Investigation 7:5, pages 711-717.
Crossref
Crossref
Yasuaki Hayashino & Hitoshi Ishii. (2015) The relationship between patient perception of healthcare provision by professionals and the self-care activity of patients with diabetes: Japanese subgroup analysis of the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Diabetology International 7:2, pages 111-118.
Crossref
Crossref
C. J. Ng, P. S. M. Lai, Y. K. Lee, S. A. Azmi & C. H. Teo. (2015) Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review. International Journal of Clinical Practice 69:10, pages 1050-1070.
Crossref
Crossref
William David Strain, Matthias Blüher & Païvi Paldánius. (2014) Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?. Diabetes Therapy 5:2, pages 347-354.
Crossref
Crossref